I will try to live as long as possible.
Dr. Ezekiel Emanuel plans to reject life-extending medical care at the age of 75. The reason he does this is quite similar to why the Kaelons commit ritual suicide in Star Trek: The Next Generation. Does this make sense?
This is a SURVEY result of Rapamycin users. Overall, it’s really good for you. It has not had a true trial as it is off-patent so it’s harder to get rich from it. Low dose use has minimal side effects if any at all. Many patients can get off-label prescription from their doctor.
Magnesium Breakthrough 10% Discount _https://bit.ly/3O5tPfu_ Code Modern10 This video brought to you by BiOptimizers.
Here Prof Kaeberlein provides some updates on rapamycin, in particular the results from the survey based trial that his team ran and thoughts on next steps for the supplement.
Continue reading “Rapamycin Update What You Need To Know | Prof Matt Kaeberlein Ep1” »
DISCLOSURE: Longevity. Technology (a brand of First Longevity Limited) has been contracted by the company featured in this article to support its current funding round. Qualifying investors can find out more via the Longevity. Technology investor portal.
This week’s Longevity Summit Dublin is in full swing, bringing together experts from around the world, fostering collaboration and knowledge exchange in the pursuit of solutions to extend human healthspan. One of the speakers during today’s sessions was Stanford professor and surgeon, Dr Vinit Mahajan, who is also Chief Medical Advisor for longevity biotech startup Mitrix Bio.
In his address to summit delegates in Dublin, Mahajan presented the company’s fascinating preclinical technology: bioreactor-grown mitochondria designed to be transplanted into the human body to regenerate organs, reverse age-related disease, and support other longevity therapies.
Researchers have determined a new feature of how the natural ends of our chromosomes are protected from harmful outcomes.
In a new study, University of Michigan researchers looked at how the DNA damage recognition process seems to know the difference between harmful DNA breaks that need repair versus the natural ends of chromosomes, called telomeres, that need to be left alone.
“If possible, you repair it, and if you can’t repair it, then the cell dies. You don’t want to keep dividing with broken DNA. That’s what happens in a normal cell, and that’s a good thing,” said Jayakrishnan Nandakumar, a professor of molecular, cellular and developmental biology.
Researchers publishing in Biogerontology have tested multiple biomarkers in an effort to use them as proxies for aging, and some of their findings were surprising. A simple study with direct […].
What if “looking your age” refers not to your face, but to your chest? Osaka Metropolitan University scientists have developed an advanced artificial intelligence (AI) model that utilizes chest radiographs to accurately estimate a patient’s chronological age. More importantly, when there is a disparity, it can signal a correlation with chronic disease.
These findings mark a leap in medical imaging, paving the way for improved early disease detection and intervention. The results are published in The Lancet Healthy Longevity.
The research team, led by graduate student Yasuhito Mitsuyama and Dr. Daiju Ueda from the Department of Diagnostic and Interventional Radiology at the Graduate School of Medicine, Osaka Metropolitan University, first constructed a deep learning-based AI model to estimate age from chest radiographs of healthy individuals.
Stem cells have been used to produce organoids that release the proteins responsible for forming dental enamel, a substance that shields teeth from harm and decay. This initiative was led by a multi-disciplinary team of researchers from the University of Washington in Seattle.
“This is a critical first step to our long-term goal to develop stem cell-based treatments to repair damaged teeth and regenerate those that are lost,” said Hai Zhang, professor of restorative dentistry at the UW School of Dentistry and one of the co – authors of the paper describing the research.
The findings are published today in the journal Developmental Cell. Ammar Alghadeer, a graduate student in Hannele Ruohola-Baker’s laboratory in the Department of Biochemistry at the UW School of Medicine was the lead author on the paper. The lab is affiliated with the UW Medicine Institute for Stem Cell and Regenerative Medicine.
23RD – 24TH AUGUST 2023 IN SOUTH AFRICA INTERNATIONAL LONGEVITY SUMMIT 23RD – 24TH AUGUST 2023 IN SOUTH AFRICA INTERNATIONALLONGEVITY SUMMIT REGISTER CALL FOR PAPERS REGISTER CALL FOR PAPERS JOIN THE EVENT WHY ATTEND THE CONFERENCE The International Longevity Summit in the most exclusive Conference for Longevity and Biotech revolution in Africa leveraging the dynamics […].
Scientist, longevity expert and biotechnology patent holder Raj Agni (aka Steven Schorr) beams in to discuss age deceleration, telomere extension and revolutionary plant-based anti-aging supplements on episode 114 of the Far Out with Faust podcast.
Raj Agni, also known as Steven M. Schorr, is a metaphysician, author, inventor, healer, alchemist, artist, musician, entrepreneur, and creator of Extended Longevity products designed to rebuild your telomeres. His clinics have operated for 14 years on Maui, Hawaii and he has treated over twenty thousand people.
Continue reading “Scientific Proof We Can Reverse Aging | Raj Agni Podcast” »
Watch the full episode and view show notes here: https://bit.ly/3Oo9mE5
Become a member to receive exclusive content: https://peterattiamd.com/subscribe/
Sign up to receive Peter’s email newsletter: https://peterattiamd.com/newsletter/
In this “Ask Me Anything” (AMA) episode, Peter delves into the realm of genetics, unraveling its connection to disease and emphasizing the value of understanding one’s genetic risks. He elucidates essential background knowledge on genetics before delving into the myriad reasons why individuals might consider genetic testing. Peter differentiates scenarios where genetic testing provides genuine insights from those where it may not be as useful. From there, Peter explores a comprehensive comparison of commercial direct-to-consumer genetic tests, providing insights on interpreting results and identifying the standout options for gaining insights into personal health.
